Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

216 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
Maser EA, Villela R, Silverberg MS, Greenberg GR. Maser EA, et al. Among authors: greenberg gr. Clin Gastroenterol Hepatol. 2006 Oct;4(10):1248-54. doi: 10.1016/j.cgh.2006.06.025. Epub 2006 Aug 22. Clin Gastroenterol Hepatol. 2006. PMID: 16931170
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. Among authors: greenberg g. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Clinical Trial.
Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
Fortinsky KJ, Kevans D, Qiang J, Xu W, Bellolio F, Steinhart H, Milgrom R, Greenberg G, Cohen Z, Macrae H, Stempak J, McLeod R, Silverberg MS. Fortinsky KJ, et al. Among authors: greenberg g. Dig Dis Sci. 2017 Jan;62(1):188-196. doi: 10.1007/s10620-016-4351-7. Epub 2016 Oct 24. Dig Dis Sci. 2017. PMID: 27778204
Functional variants of OCTN cation transporter genes are associated with Crohn disease.
Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffiths AM, St George-Hyslop PH, Siminovitch KA. Peltekova VD, et al. Among authors: greenberg g. Nat Genet. 2004 May;36(5):471-5. doi: 10.1038/ng1339. Epub 2004 Apr 11. Nat Genet. 2004. PMID: 15107849
Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
Panaccione R, Fedorak RN, Aumais G, Bernstein CN, Bitton A, Croitoru K, Enns R, Feagan B, Fishman M, Greenberg G, Griffiths A, Marshall JK, Rasul I, Sadowski D, Seidman E, Steinhart H, Sutherland L, Walli E, Wild G, Williams CN, Zachos M; Canadian Association of Gastroenterology. Panaccione R, et al. Among authors: greenberg g. Can J Gastroenterol. 2004 Aug;18(8):503-8. doi: 10.1155/2004/670161. Can J Gastroenterol. 2004. PMID: 15372114 No abstract available.
Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease.
Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N, Steinhart H, Greenberg G. Siffledeen JS, et al. Among authors: greenberg g. Clin Gastroenterol Hepatol. 2005 Feb;3(2):122-32. doi: 10.1016/s1542-3565(04)00663-9. Clin Gastroenterol Hepatol. 2005. PMID: 15704046 Clinical Trial.
Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease.
Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N, Seinhart H, Greenberg G. Siffledeen JS, et al. Among authors: greenberg g. Inflamm Bowel Dis. 2004 May;10(3):220-8. doi: 10.1097/00054725-200405000-00007. Inflamm Bowel Dis. 2004. PMID: 15290915
Metabolic advantages of spreading the nutrient load: effects of increased meal frequency in non-insulin-dependent diabetes.
Jenkins DJ, Ocana A, Jenkins AL, Wolever TM, Vuksan V, Katzman L, Hollands M, Greenberg G, Corey P, Patten R, et al. Jenkins DJ, et al. Among authors: greenberg g. Am J Clin Nutr. 1992 Feb;55(2):461-7. doi: 10.1093/ajcn/55.2.461. Am J Clin Nutr. 1992. PMID: 1734685
Low glycemic index foods and reduced glucose, amino acid, and endocrine responses in cirrhosis.
Jenkins DJ, Shapira N, Greenberg G, Jenkins AL, Collier GR, Poduch C, Wolever TM, Anderson GH, Blendis LM. Jenkins DJ, et al. Among authors: greenberg g. Am J Gastroenterol. 1989 Jul;84(7):732-9. Am J Gastroenterol. 1989. PMID: 2500846
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG; REACT Study Investigators. Khanna R, et al. Among authors: greenberg gr. Lancet. 2015 Nov 7;386(10006):1825-34. doi: 10.1016/S0140-6736(15)00068-9. Epub 2015 Sep 3. Lancet. 2015. PMID: 26342731 Clinical Trial.
216 results
Jump to page
Feedback